Author: RevHealth

Posted Date:

May 1, 2026

Alcresta Therapeutics Announces Preclinical Data Evaluating RELiZORBneo Cartridge Use in Neonatal Murine Model of Necrotizing Enterocolitis

RevHealth

May 1, 2026
/C O R R E C T I O N — Theranica/

RevHealth

February 24, 2026
Study Confirms Safety of Using Theranica’s Nerivio® REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices

RevHealth

February 24, 2026